Vaccination in a Post-Pandemic World
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 1177
Special Issue Editor
Interests: vaccines; COVID-19; influezna; epidemiology; viral diseases; primary care; travel medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immunization is one of the most significant discoveries of modern medicine. However, the effectiveness of medicine depends on its acceptance by the patient, which requires social acceptance. The COVID-19 pandemic has brought immunization to the forefront of discussions, including vaccination against COVID-19. Before the pandemic, most people associated vaccination only with childhood immunization, and many were unaware of the vaccines recommended for adults. While the pandemic has helped to initiate a global conversation on immunization for all age groups, it has also led to a rise in anti-vaccination groups and a decrease in vaccination interest among specific populations. This trend is concerning and could have severe negative consequences for public health. Therefore, assessing the current willingness to receive vaccinations among pediatric and adult groups is important. It is also essential to use the post-pandemic period to increase immunization uptake in all age groups. This Special Issue aims to evaluate how the COVID-19 pandemic has impacted vaccination strategies, how the post-pandemic period can be utilized to build global confidence in vaccination and to assess the current levels of vaccine acceptance in each age group.
Dr. Mateusz Babicki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- COVID-19
- vaccinations
- post-pandemic
- vaccination strategies
- global health
- public health
- vaccine hesitancy
- attitudes towards vaccination
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
